PCSS MOUD Online Case-based Learning Collaboratives Session 1: OUD and Pregnancy
Join our 4-session online case-based learning collaborative series focused on treating opioid use disorder. Delve into best practices on OUD and Pregnancy and explore real-world cases provided by addiction experts, applying knowledge to practical situations. Each session is presented live online and spans 1.5 hours.
Pregnancy and Buprenorphine Treatment
View Guidance.
Opioid Use Disorder in Pregnant and Postpartum People: The Treatment and Policy Landscape
Opioid use disorder (OUD) can be a fatal addiction with complex implications for new and/or expecting mothers. OUD challenges can lead to many complications for mother and child, including low birth weight, clinical challenges with medical dosing and increased risk of accidental death. In the U.S. alone, a baby is born passively dependent every 15 minutes. To ensure best health outcomes for both mother and child, policies must allow engagement in evidence-based treatment and protect clients from legal ramifications. Hear from a physician, clinic director and an individual with lived experience to broaden understandings about the treatment and policy landscape for pregnant and postpartum women with OUD.
20: Treating Pregnant People for Opioid Use Disorder: Clinical Challenges
Opioid use disorder (OUD) among women and people who become pregnant is increasing in prevalence in clinical settings. The standard of care is to provide buprenorphine or methadone as a part of a complete treatment approach during pregnancy and beyond the postpartum period. This module reviews the historical and current context of opioid use among women and birthing people during pregnancy. It compares pharmacological treatment options for women and people who become pregnant with an OUD and also discusses the issues with detoxification or medically assisted withdrawal from opioids during pregnancy. Issues related to the treatment of OUD during pregnancy and in the postpartum period for the birthing person, fetus and child will also be discussed (e.g., induction, dosing, pain management, neonatal withdrawal and how to reduce its severity).
Pregnancy: Methadone and Buprenorphine
Some women are surprised to learn they got pregnant while using heroin, Oxycontin, Percocet or other pain medications that can be misused (known as opioid drugs). You, along with family and friends, may worry about your drug use and if it could affect your baby.
Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants
SAMHSA created this Clinical Guidance to meet an urgent need among professionals who care for women with OUD and substance exposed infants for reliable, useful, and accurate information that can be applied in clinical practice to optimize the outcome for both mother and infant.
ATTC for Pregnant and Postpartum Women
The Tools for Treatment site was established by the The ATTC Center of Excellence on Behavioral Health for Pregnant and Women and Their Families (ATTC CoE-PPW).
OWH: Opioids and Women Final Report
This report was developed as part of an initiative of the U.S. Department of Health and Human Services (HHS) Office on Women’s Health (OWH) to examine prevention, treatment, and recovery issues for women who misuse opioids, have opioid use disorders (OUDs), and/or overdose on opioids.
